Kallu personal page - To The Moon

Kallu

Kallu

To achieve your own goals, start by helping others achieve theirs. Study and steady wins the race.

52Follow

24Followers

1Topic

0Badge

03-24

$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage

2024-12-17

$Tonix Pharmaceuticals(TNXP)$ 5$ soon @Barcode @TigerGPT @Tiger_SG

2024-12-16

$Tonix Pharmaceuticals(TNXP)$ go go @TigerGPT $Tonix Pharmaceuticals(TNXP)$

2024-10-30

$Trump Media & Technology(DJT)$ it's glitch.. 60$ is loading.. @@Barcode you're strong analysis required here to save me 😭😭😭$Trump Media & Technology(DJT)$

2024-10-15

"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything."$NVIDIA Corp(NVDA)$ $Aspen Aerogels(ASPN)$ $Tiger Brokers(TIGR)$$NASDAQ 100(NDX)$ $.SPX(.SPX)$ @Barcode @TigerGPT Why!!!

2024-11-20

$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$

@Barcode @TigerGPT $Tonix Pharmaceuticals(TNXP)$

2024-10-08

$Vincera Pharma, Inc.(VINC)$ buy soon before the blast

Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours

01-24

Waiting badly to come out $Tiger Brokers(TIGR)$ //@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind

@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow

2024-10-14

@Barcode @TigerGPT $Red Cat Holdings Inc.(RCAT)$ Join the drone show mate @Barcode

U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors

2024-09-30

$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$

03-06

The investor summit is currently $Tonix Pharmaceuticals(TNXP)$ happening. It might be a good opportunity to secure some funding.

@Boybabyrage:$Tonix Pharmaceuticals(TNXP)$ Someone has any ideas why the stock suddenly goes up... another manipulation?

2024-11-13

$NIO Inc.(NIO)$ im exhausted from all the misleading positive reports, only to see stocks stagnate @Barcode @TigerGPT answer me why $NIO Inc.(NIO)$ is not performing well.

Is Nio About to Shift Into a Higher Gear?

01-06

$CN Energy Group Inc.(CNEY)$ why it's raising @Boybabyrage @TigerGPT

02-18

$Intel(INTC)$ there you go $Intel(INTC)$ @Barcode @TigerGPT

01-22

$Canoo Inc.(GOEV)$ game over!!! Does anyone have any hope??

2024-09-18

$Intuitive Machines(LUNR)$ $Intuitive Machines(LUNR)$ just a good start..thanks to the mid-autumn festival

2024-12-11

$Taboola Com Ltd(TBLA)$ $Taboola Com Ltd(TBLA)$ still not selling @Barcode @TigerGPT

2024-10-29

2024-10-21

$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$

@TigerGPT Any good news about $Tonix Pharmaceuticals(TNXP)$

2024-10-04

$Spirit Airlines(SAVE)$ $Spirit Airlines(SAVE)$

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4156648821928502","uuid":"4156648821928502","gmtCreate":1693545706295,"gmtModify":1730966832917,"name":"Kallu","pinyin":"kallu","introduction":"","introductionEn":"","signature":"To achieve your own goals, start by helping others achieve theirs. Study and steady wins the race.","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":24,"headSize":52,"tweetSize":166,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.27","exceedPercentage":"80.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":417123775844896,"gmtCreate":1742855218399,"gmtModify":1742855221505,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Today's profit&nbsp;","listText":"Today's profit&nbsp;","text":"Today's profit","images":[{"img":"https://community-static.tradeup.com/news/5bcb0b946cd0202ac8558d42115f604d","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/417123775844896","isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":417114634396144,"gmtCreate":1742852985057,"gmtModify":1742852989691,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Today's profit&nbsp;","listText":"Today's profit&nbsp;","text":"Today's profit","images":[{"img":"https://community-static.tradeup.com/news/ac208355f849d305a4152a1c60802228","width":"1094","height":"1364"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/417114634396144","isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":417093769871696,"gmtCreate":1742848257963,"gmtModify":1742848261615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Replying to <a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:bro sold at 34<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>//<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","listText":"Replying to <a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:bro sold at 34<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>//<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","text":"Replying to @Boybabyrage:bro sold at 34 $Tonix Pharmaceuticals(TNXP)$ //@Boybabyrage:I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/417093769871696","repostId":"416933179142616","repostType":1,"repost":{"id":416933179142616,"gmtCreate":1742791471694,"gmtModify":1742805914615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage","images":[{"img":"https://community-static.tradeup.com/news/ffaf1c513cfadb19fec35402ad5f97e2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/416933179142616","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":416935226139088,"gmtCreate":1742809460644,"gmtModify":1742809464338,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Hold for long-term","listText":"Hold for long-term","text":"Hold for long-term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/416935226139088","repostId":"416933179142616","repostType":1,"repost":{"id":416933179142616,"gmtCreate":1742791471694,"gmtModify":1742805914615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage","images":[{"img":"https://community-static.tradeup.com/news/ffaf1c513cfadb19fec35402ad5f97e2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/416933179142616","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":416933179142616,"gmtCreate":1742791471694,"gmtModify":1742805914615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage","images":[{"img":"https://community-static.tradeup.com/news/ffaf1c513cfadb19fec35402ad5f97e2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":9,"repostSize":97,"link":"https://ttm.financial/post/416933179142616","isVote":1,"tweetType":1,"viewCount":2198,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","text":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","html":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":416947950154032,"gmtCreate":1742778872779,"gmtModify":1742778876154,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"dead stock <a href=\"https://ttm.financial/S/ASPN\"> $Aspen Aerogels(ASPN)$ </a>","listText":"dead stock <a href=\"https://ttm.financial/S/ASPN\"> $Aspen Aerogels(ASPN)$ </a>","text":"dead stock $Aspen Aerogels(ASPN)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/416947950154032","repostId":"360647586509032","repostType":1,"repost":{"id":360647586509032,"gmtCreate":1729090159684,"gmtModify":1729090168765,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> I took my gains and added to my capital. What an 😇 🔺🅱️🆄🅻🅻🅸🆂🅷 Source: Stock Titan Aspen Aerogels (NYSE: ASPN) has received a conditional commitment from the U.S. Department of Energy for a proposed loan of up to $670.6 million to finance the construction of its second aerogel manufacturing facility in Register, Georgia. The loan, structured as project financing, would fully fund the remaining CAPEX needed to complete the plant. The Register Plant is designed to manufacture PyroThin® aerogel blankets, with an estimated revenue capacity of $1.2B - $1.6B. Additionally, Aspen announced Q3 2024 preliminary financial results, including revenue of approximately $117 million, a net loss of about $13 million, and Adjusted EBITDA of ap","listText":"<a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> I took my gains and added to my capital. What an 😇 🔺🅱️🆄🅻🅻🅸🆂🅷 Source: Stock Titan Aspen Aerogels (NYSE: ASPN) has received a conditional commitment from the U.S. Department of Energy for a proposed loan of up to $670.6 million to finance the construction of its second aerogel manufacturing facility in Register, Georgia. The loan, structured as project financing, would fully fund the remaining CAPEX needed to complete the plant. The Register Plant is designed to manufacture PyroThin® aerogel blankets, with an estimated revenue capacity of $1.2B - $1.6B. Additionally, Aspen announced Q3 2024 preliminary financial results, including revenue of approximately $117 million, a net loss of about $13 million, and Adjusted EBITDA of ap","text":"$Aspen Aerogels(ASPN)$ I took my gains and added to my capital. What an 😇 🔺🅱️🆄🅻🅻🅸🆂🅷 Source: Stock Titan Aspen Aerogels (NYSE: ASPN) has received a conditional commitment from the U.S. Department of Energy for a proposed loan of up to $670.6 million to finance the construction of its second aerogel manufacturing facility in Register, Georgia. The loan, structured as project financing, would fully fund the remaining CAPEX needed to complete the plant. The Register Plant is designed to manufacture PyroThin® aerogel blankets, with an estimated revenue capacity of $1.2B - $1.6B. Additionally, Aspen announced Q3 2024 preliminary financial results, including revenue of approximately $117 million, a net loss of about $13 million, and Adjusted EBITDA of ap","images":[{"img":"https://community-static.tradeup.com/news/7edf743b35f4ce0cf87abc4383f69338","width":"972","height":"1631"},{"img":"https://community-static.tradeup.com/news/812196fb0aeb74b4b319f550d438a40b","width":"1212","height":"848"},{"img":"https://community-static.tradeup.com/news/c36b55c754c9f5b01c49940581be8239","width":"1000","height":"563"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360647586509032","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":410631608127672,"gmtCreate":1741278165878,"gmtModify":1741278302465,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Tiger_SG $Tonix Pharmaceuticals(TNXP)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410631608127672","isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":410631691547000,"gmtCreate":1741278128028,"gmtModify":1741278132956,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Replying to <a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:Yes, bro very true.. It's up and sold 20%. Still holding it for 25$ <a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/U/4178332581629092\"> @Boybabyrage </a><a href=\"https://ttm.financial/U/4191647544371950\"> @DailyTradingInsights </a>//<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company","listText":"Replying to <a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:Yes, bro very true.. It's up and sold 20%. Still holding it for 25$ <a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/U/4178332581629092\"> @Boybabyrage </a><a href=\"https://ttm.financial/U/4191647544371950\"> @DailyTradingInsights </a>//<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage</a>:hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company","text":"Replying to @Boybabyrage:Yes, bro very true.. It's up and sold 20%. Still holding it for 25$ @Tiger_SG @Boybabyrage @DailyTradingInsights //@Boybabyrage:hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410631691547000","repostId":"410494268072200","repostType":1,"repost":{"id":410494268072200,"gmtCreate":1741228029905,"gmtModify":1741229653185,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA.<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a><a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>","listText":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA.<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a><a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>","text":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA. $Tonix Pharmaceuticals(TNXP)$ @Tiger_SG $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/a2af1335a36277543f082a5a18f211bb"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410494268072200","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":410631949181224,"gmtCreate":1741278021010,"gmtModify":1741278024495,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"The investor summit is currently<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a> happening. It might be a good opportunity to secure some funding.","listText":"The investor summit is currently<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a> happening. It might be a good opportunity to secure some funding.","text":"The investor summit is currently $Tonix Pharmaceuticals(TNXP)$ happening. It might be a good opportunity to secure some funding.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/410631949181224","repostId":"410630392594784","repostType":1,"repost":{"id":410630392594784,"gmtCreate":1741277520410,"gmtModify":1741277523662,"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> Someone has any ideas why the stock suddenly goes up... another manipulation?&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> Someone has any ideas why the stock suddenly goes up... another manipulation?&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ Someone has any ideas why the stock suddenly goes up... another manipulation?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410630392594784","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":410494268072200,"gmtCreate":1741228029905,"gmtModify":1741229653185,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA.<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a><a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>","listText":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA.<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a><a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a>","text":"Yes, I was in profit until the reverse split. I'm a big dumbass for failing to sell, and now I'm trapped in a bad situation. It will take another 5 MONTHS to get it approved by the FDA. $Tonix Pharmaceuticals(TNXP)$ @Tiger_SG $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/a2af1335a36277543f082a5a18f211bb"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://ttm.financial/post/410494268072200","repostId":"409983907291424","repostType":1,"repost":{"id":409983907291424,"gmtCreate":1741083593011,"gmtModify":1741084023627,"author":{"id":"4176111593735382","authorId":"4176111593735382","name":"Ren88","avatar":"https://community-static.tradeup.com/news/95bbdb262be9a0fc747d5c4c022ef130","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4176111593735382","idStr":"4176111593735382"},"themes":[],"title":"TNXP. A lost cause?","htmlText":"This stock had been spirally down with low volume. Too much people looking to sell.&nbsp;","listText":"This stock had been spirally down with low volume. Too much people looking to sell.&nbsp;","text":"This stock had been spirally down with low volume. Too much people looking to sell.","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/409983907291424","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company","text":"hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company","html":"hahaha you are not the only one bro. I could earn a lot if I cashed out that time, but chose to believe in the company....now we are in a bad situation. Hoping some big pharmacy buy this company"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":410605330620848,"gmtCreate":1741227482170,"gmtModify":1741227486223,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"IM-2 is loading soon. It will recover. All the best, buddy! <a href=\"https://ttm.financial/S/LUNR\"> $Intuitive Machines(LUNR)$ </a><a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a><a href=\"https://ttm.financial/U/4191647544371950\"> @DailyTradingInsights </a><a href=\"https://ttm.financial/S/LUNR\"> $Intuitive Machines(LUNR)$ </a>","listText":"IM-2 is loading soon. It will recover. All the best, buddy! <a href=\"https://ttm.financial/S/LUNR\"> $Intuitive Machines(LUNR)$ </a><a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a><a href=\"https://ttm.financial/U/4191647544371950\"> @DailyTradingInsights </a><a href=\"https://ttm.financial/S/LUNR\"> $Intuitive Machines(LUNR)$ </a>","text":"IM-2 is loading soon. It will recover. All the best, buddy! $Intuitive Machines(LUNR)$ $Tiger Brokers(TIGR)$ @DailyTradingInsights $Intuitive Machines(LUNR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410605330620848","repostId":"408212185702792","repostType":1,"repost":{"id":408212185702792,"gmtCreate":1740682024041,"gmtModify":1740682133143,"author":{"id":"3576659620255087","authorId":"3576659620255087","name":"eggbenji","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576659620255087","idStr":"3576659620255087"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;","text":"$Intuitive Machines(LUNR)$ $Intuitive Machines(LUNR)$","images":[{"img":"https://community-static.tradeup.com/news/3bfbe7e403c5a0350895cb850ca10dde","width":"894","height":"1564"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/408212185702792","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":410269381120072,"gmtCreate":1741142919472,"gmtModify":1741143104533,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a><v-v data-views=\"1\"></v-v> IM2&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/3527667673047996\">@SGX_Stars </a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a><v-v data-views=\"1\"></v-v> IM2&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/3527667673047996\">@SGX_Stars </a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>","text":"$Intuitive Machines(LUNR)$ IM2 @Barcode @SGX_Stars $Intuitive Machines(LUNR)$ $Intuitive Machines(LUNR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/410269381120072","isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":408536715690240,"gmtCreate":1740712326154,"gmtModify":1740712330014,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Hold it","listText":"Hold it","text":"Hold it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/408536715690240","repostId":"408078116757768","repostType":1,"repost":{"id":408078116757768,"gmtCreate":1740626266057,"gmtModify":1740626270281,"author":{"id":"4087736393056860","authorId":"4087736393056860","name":"Sda","avatar":"https://community-static.tradeup.com/news/297c9c624b8a15bfaaf9536fe9002df9","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4087736393056860","idStr":"4087736393056860"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLL\">$Direxion Daily TSLA Bull 2X Shares(TSLL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSLL\">$Direxion Daily TSLA Bull 2X Shares(TSLL)$ </a>&nbsp;","text":"$Direxion Daily TSLA Bull 2X Shares(TSLL)$","images":[{"img":"https://community-static.tradeup.com/news/9f2beed648db727d604374f91b08fd04","width":"596","height":"1043"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/408078116757768","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":408430916014304,"gmtCreate":1740686209617,"gmtModify":1740692359971,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Bloodbath [Happy]","listText":"Bloodbath [Happy]","text":"Bloodbath [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/408430916014304","repostId":"408107132350824","repostType":1,"repost":{"id":408107132350824,"gmtCreate":1740625158236,"gmtModify":1740693602212,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"themes":[],"htmlText":"💹🪙🪙🪙📈💹 The market may have its ups and downs, but one thing is on a steady uptrend, my Tiger Coin balance! 🪙🪙🪙 Another 50 shiny coins from Daily Discussion, stacking up alongside my picked post rewards, making this week feel like a perfectly executed breakout trade. A massive thank you to my incredible followers, you’re the volume surge behind every rally, the strong support at every key level, and the momentum behind every breakout. Your engagement isn’t just interaction, it’s the fuel that keeps the Barcode trend going strong, and I appreciate every one of you. 🥳🙌 A BIG congratulations to my fellow winners yourcelesttyy, MaverickWealthBuilder, Mickey082024, JC888 and nerdbull1669, great to be in such strong company. With six top Tigers dominating the leaderboard yesterday, it’s clear tha","listText":"💹🪙🪙🪙📈💹 The market may have its ups and downs, but one thing is on a steady uptrend, my Tiger Coin balance! 🪙🪙🪙 Another 50 shiny coins from Daily Discussion, stacking up alongside my picked post rewards, making this week feel like a perfectly executed breakout trade. A massive thank you to my incredible followers, you’re the volume surge behind every rally, the strong support at every key level, and the momentum behind every breakout. Your engagement isn’t just interaction, it’s the fuel that keeps the Barcode trend going strong, and I appreciate every one of you. 🥳🙌 A BIG congratulations to my fellow winners yourcelesttyy, MaverickWealthBuilder, Mickey082024, JC888 and nerdbull1669, great to be in such strong company. With six top Tigers dominating the leaderboard yesterday, it’s clear tha","text":"💹🪙🪙🪙📈💹 The market may have its ups and downs, but one thing is on a steady uptrend, my Tiger Coin balance! 🪙🪙🪙 Another 50 shiny coins from Daily Discussion, stacking up alongside my picked post rewards, making this week feel like a perfectly executed breakout trade. A massive thank you to my incredible followers, you’re the volume surge behind every rally, the strong support at every key level, and the momentum behind every breakout. Your engagement isn’t just interaction, it’s the fuel that keeps the Barcode trend going strong, and I appreciate every one of you. 🥳🙌 A BIG congratulations to my fellow winners yourcelesttyy, MaverickWealthBuilder, Mickey082024, JC888 and nerdbull1669, great to be in such strong company. With six top Tigers dominating the leaderboard yesterday, it’s clear tha","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/408107132350824","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":407034121076912,"gmtCreate":1740391448226,"gmtModify":1740391451998,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Hope recovered","listText":"Hope recovered","text":"Hope recovered","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/407034121076912","repostId":"393210362978728","repostType":1,"repost":{"id":393210362978728,"gmtCreate":1737036116718,"gmtModify":1737358530960,"author":{"id":"4173431176419152","authorId":"4173431176419152","name":"Golden Fish","avatar":"https://community-static.tradeup.com/news/24bb78dd75a5d51722508f5fd5bf8b67","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4173431176419152","idStr":"4173431176419152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a> 🥺","listText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a> 🥺","text":"$CN Energy Group Inc.(CNEY)$ 🥺","images":[{"img":"https://community-static.tradeup.com/news/18fa498703bf0055afb541e06a058385","width":"696","height":"1122"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/393210362978728","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":405917425750256,"gmtCreate":1740128551883,"gmtModify":1740128554890,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Yes hold it","listText":"Yes hold it","text":"Yes hold it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/405917425750256","repostId":"405896362930520","repostType":1,"isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":405085459796392,"gmtCreate":1739918741057,"gmtModify":1739937578827,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v> there you go&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v> there you go&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","text":"$Intel(INTC)$ there you go $Intel(INTC)$ @Barcode @TigerGPT","images":[{"img":"https://community-static.tradeup.com/news/41c6496ea10ce42274171e97836f8ae0","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":1,"link":"https://ttm.financial/post/405085459796392","isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4141429963588842","idStr":"4141429963588842"},"content":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions.","text":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions.","html":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":404593086238776,"gmtCreate":1739801957518,"gmtModify":1739801959910,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Intel(INTC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/404593086238776","repostId":"2511937358","repostType":4,"repost":{"id":"2511937358","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1739800800,"share":"https://ttm.financial/m/news/2511937358?lang=&edition=full_marsco","pubTime":"2025-02-17 22:00","market":"us","language":"en","title":"Here’s How Intel’s Stock Charts Look After Its Big Rally. Should You Buy It?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511937358","media":"Dow Jones","summary":"From that perspective, it looks like the stock just ran into a massive overhang of resistance that has already worked once. So the answer to the original question becomes easier: Sell at least some, perhaps enough to lower the breakeven point of the position below the support zone. While there are technical signs the trade could very well work out long term, it could be quite a slog.Photo:","content":"<html><head></head><body><p>The chip maker’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7a9d4efd975580033d9e9f943dc80d58\" alt=\"Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.\" title=\"Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.\" tg-width=\"925\" tg-height=\"614\"/><span>Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.</span></p><p>Whether something looks bullish or bearish is in the eye of the beholder.</p><p style=\"text-align: start;\">Intel’s stock just had itsbest week in 25 years. How that move is interpreted by those who own shares depends on when and where they bought them, and whether they bought them as a short-term trade or as a longer-term investment.</p><p>On a shorter-term basis, the stock looks like it broke out in a big way. Longer-term trend followers may have been put on notice, but still don’t have reason to worry that the status quo won’t continue — at least for a while.</p><p>Since there are too many possible perspectives to run through, let’s try to see things through the eyes of the hypothetical shorter-term investor who bought the stock just before the breakout, to understand what course of action they might want to take after the rally. That could also help provide some insight for those with different perspectives.</p><p>First, consider that the prerally buyer had watched the stock have its worst day in 50 years in August, then saw it make several pushes below the $20 level since then — including after the chief executive got pushed out on Dec. 2 — but fail to get below $18.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/27675059abab1d6ae7e2c9269d2cf934\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1047\" tg-height=\"727\"/><span>Photo: FactSet, MarketWatch</span></p><p>Then earlier this month, bears took another whack at a sub-$20 move. But after a number of failures to push below $19, let’s say our prerally investor decided to take a chance and buy.</p><p style=\"text-align: start;\">With this week’s rally, the stock broke through a well-defined, year-long downward trend line to suggest a new bullish trend has just kicked off. That fact that the trend line had no less than five points on it plus a close call — there only needs to be three points to define a trendline — may give the breakout even more muscle.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/229e4ad562a6f29eac7143358d83fd04\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1046\" tg-height=\"718\"/><span>Photo: FactSet, MarketWatch</span></p><p>After the stock pulled back on Friday, that prerally buyer may be asking themselves whether they should book at least some profits.</p><p>There’s a thought among chart watchers that when you’ve reached a crossroads in your decision-making, try to look at the situation through someone else’s eyes.</p><p>Some would turn the chart upside down and look at it in a mirror.</p><p style=\"text-align: start;\">Another way is to pull way back, take a longer-term view of the chart, then ask yourself the opposite question.</p><p style=\"text-align: start;\">For example, that prerally buyer should look at a five-year chart, and rather than wonder whether they should sell some, ask themselves: “Would I buy that?”</p><p style=\"text-align: start;\">From that perspective, it looks like the stock just ran into a massive overhang of resistance that has already worked once. So the answer to the original question becomes easier: Sell at least some, perhaps enough to lower the breakeven point of the position below the support zone. While there are technical signs the trade could very well work out long term, it could be quite a slog.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/b5e9649a430a5b979303709f00de52e5\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1047\" tg-height=\"723\"/><span>Photo: FactSet, MarketWatch</span></p><p style=\"text-align: start;\">Previously broken support levels tend to morph into resistance when they are retested. And the more important the support, the stronger the resistance becomes. The idea is that those who bought at support, and still held it through the breakdown, would likely become sellers happy to break even if given the chance.</p><p style=\"text-align: start;\">For Intel’s stock, support around $25 first tested in October 2022 was huge, as it stopped an 18-month drop that appeared to have started accelerating. The third attempt by bears to break that support failed miserably, and launched a doubling in the stock price.</p><p style=\"text-align: start;\">That resistance worked very well in bulls’ first attempt at a rally, so there’s a good chance it’ll work again, at least for a while. Even if it does give way, it won’t be easy, and the prerally buyer would probably have to suffer through multiple pullbacks that question their resolve.</p><p style=\"text-align: start;\">And if or when the resistance breaks, there’s another zone of resistance just above, at the top of the August 2024 breakdown gap, followed by previously strong prebreakdown support around the $30 level.</p><p style=\"text-align: start;\">So a quick booking of some profit would not only ease any coming stress, it would also provide some options depending on what happens next. Trading positions don’t need to be all or nothing, as the amount sold to book some profit could always be repurchased on a dip or after confirmation of a breakout.</p><p style=\"text-align: start;\">The chance, and urge, to repurchase could come quite soon. Despite all the daunting resistance, bulls have done enough short-term work to provide some real hope that something bigger is building.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5ed836ee12e99bfd6ecde7a909860595\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1045\" tg-height=\"718\"/><span>Photo: FactSet, MarketWatch</span></p><p style=\"text-align: start;\">There’s should now be strong support just below current prices, as bears should be unwilling to try another push lower. And while previous bounces off support petered out well below the 200-day moving average, which is viewed by many as a long-term trend dividing line, the latest has peaked above that line — twice.</p><p style=\"text-align: start;\">The kicker is, the underlying rate-of-change indicator shows momentum has been building for a rally for months, as each failure by bears to break support actually added to bulls’ strength.</p><p style=\"text-align: start;\">While rising momentum at a time when the stock stays flat for falls — bullish technical divergence — isn’t a reason by itself to buy, it can act as a warning for when a breakout does come to take the rally seriously.</p><p style=\"text-align: start;\">So other than the prerally buyer, what message may these charts be sending to someone who is considering taking a shot at buying?</p><p style=\"text-align: start;\">It’s probably best not to buy within the long-term resistance zone — but perhaps be ready to buy on the dip into close support (with a stop loss on a break of $18). And if resistance does eventually give way, the new trend will likely be a pretty long one.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s How Intel’s Stock Charts Look After Its Big Rally. Should You Buy It?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s How Intel’s Stock Charts Look After Its Big Rally. Should You Buy It?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-17 22:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>The chip maker’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7a9d4efd975580033d9e9f943dc80d58\" alt=\"Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.\" title=\"Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.\" tg-width=\"925\" tg-height=\"614\"/><span>Intel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.</span></p><p>Whether something looks bullish or bearish is in the eye of the beholder.</p><p style=\"text-align: start;\">Intel’s stock just had itsbest week in 25 years. How that move is interpreted by those who own shares depends on when and where they bought them, and whether they bought them as a short-term trade or as a longer-term investment.</p><p>On a shorter-term basis, the stock looks like it broke out in a big way. Longer-term trend followers may have been put on notice, but still don’t have reason to worry that the status quo won’t continue — at least for a while.</p><p>Since there are too many possible perspectives to run through, let’s try to see things through the eyes of the hypothetical shorter-term investor who bought the stock just before the breakout, to understand what course of action they might want to take after the rally. That could also help provide some insight for those with different perspectives.</p><p>First, consider that the prerally buyer had watched the stock have its worst day in 50 years in August, then saw it make several pushes below the $20 level since then — including after the chief executive got pushed out on Dec. 2 — but fail to get below $18.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/27675059abab1d6ae7e2c9269d2cf934\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1047\" tg-height=\"727\"/><span>Photo: FactSet, MarketWatch</span></p><p>Then earlier this month, bears took another whack at a sub-$20 move. But after a number of failures to push below $19, let’s say our prerally investor decided to take a chance and buy.</p><p style=\"text-align: start;\">With this week’s rally, the stock broke through a well-defined, year-long downward trend line to suggest a new bullish trend has just kicked off. That fact that the trend line had no less than five points on it plus a close call — there only needs to be three points to define a trendline — may give the breakout even more muscle.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/229e4ad562a6f29eac7143358d83fd04\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1046\" tg-height=\"718\"/><span>Photo: FactSet, MarketWatch</span></p><p>After the stock pulled back on Friday, that prerally buyer may be asking themselves whether they should book at least some profits.</p><p>There’s a thought among chart watchers that when you’ve reached a crossroads in your decision-making, try to look at the situation through someone else’s eyes.</p><p>Some would turn the chart upside down and look at it in a mirror.</p><p style=\"text-align: start;\">Another way is to pull way back, take a longer-term view of the chart, then ask yourself the opposite question.</p><p style=\"text-align: start;\">For example, that prerally buyer should look at a five-year chart, and rather than wonder whether they should sell some, ask themselves: “Would I buy that?”</p><p style=\"text-align: start;\">From that perspective, it looks like the stock just ran into a massive overhang of resistance that has already worked once. So the answer to the original question becomes easier: Sell at least some, perhaps enough to lower the breakeven point of the position below the support zone. While there are technical signs the trade could very well work out long term, it could be quite a slog.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/b5e9649a430a5b979303709f00de52e5\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1047\" tg-height=\"723\"/><span>Photo: FactSet, MarketWatch</span></p><p style=\"text-align: start;\">Previously broken support levels tend to morph into resistance when they are retested. And the more important the support, the stronger the resistance becomes. The idea is that those who bought at support, and still held it through the breakdown, would likely become sellers happy to break even if given the chance.</p><p style=\"text-align: start;\">For Intel’s stock, support around $25 first tested in October 2022 was huge, as it stopped an 18-month drop that appeared to have started accelerating. The third attempt by bears to break that support failed miserably, and launched a doubling in the stock price.</p><p style=\"text-align: start;\">That resistance worked very well in bulls’ first attempt at a rally, so there’s a good chance it’ll work again, at least for a while. Even if it does give way, it won’t be easy, and the prerally buyer would probably have to suffer through multiple pullbacks that question their resolve.</p><p style=\"text-align: start;\">And if or when the resistance breaks, there’s another zone of resistance just above, at the top of the August 2024 breakdown gap, followed by previously strong prebreakdown support around the $30 level.</p><p style=\"text-align: start;\">So a quick booking of some profit would not only ease any coming stress, it would also provide some options depending on what happens next. Trading positions don’t need to be all or nothing, as the amount sold to book some profit could always be repurchased on a dip or after confirmation of a breakout.</p><p style=\"text-align: start;\">The chance, and urge, to repurchase could come quite soon. Despite all the daunting resistance, bulls have done enough short-term work to provide some real hope that something bigger is building.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5ed836ee12e99bfd6ecde7a909860595\" alt=\"Photo: FactSet, MarketWatch\" title=\"Photo: FactSet, MarketWatch\" tg-width=\"1045\" tg-height=\"718\"/><span>Photo: FactSet, MarketWatch</span></p><p style=\"text-align: start;\">There’s should now be strong support just below current prices, as bears should be unwilling to try another push lower. And while previous bounces off support petered out well below the 200-day moving average, which is viewed by many as a long-term trend dividing line, the latest has peaked above that line — twice.</p><p style=\"text-align: start;\">The kicker is, the underlying rate-of-change indicator shows momentum has been building for a rally for months, as each failure by bears to break support actually added to bulls’ strength.</p><p style=\"text-align: start;\">While rising momentum at a time when the stock stays flat for falls — bullish technical divergence — isn’t a reason by itself to buy, it can act as a warning for when a breakout does come to take the rally seriously.</p><p style=\"text-align: start;\">So other than the prerally buyer, what message may these charts be sending to someone who is considering taking a shot at buying?</p><p style=\"text-align: start;\">It’s probably best not to buy within the long-term resistance zone — but perhaps be ready to buy on the dip into close support (with a stop loss on a break of $18). And if resistance does eventually give way, the new trend will likely be a pretty long one.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2511937358","content_text":"The chip maker’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fastIntel’s stock looks like it broke out in a big way on the shorter-term chart — but taking a longer-term investing view warns: not so fast.Whether something looks bullish or bearish is in the eye of the beholder.Intel’s stock just had itsbest week in 25 years. How that move is interpreted by those who own shares depends on when and where they bought them, and whether they bought them as a short-term trade or as a longer-term investment.On a shorter-term basis, the stock looks like it broke out in a big way. Longer-term trend followers may have been put on notice, but still don’t have reason to worry that the status quo won’t continue — at least for a while.Since there are too many possible perspectives to run through, let’s try to see things through the eyes of the hypothetical shorter-term investor who bought the stock just before the breakout, to understand what course of action they might want to take after the rally. That could also help provide some insight for those with different perspectives.First, consider that the prerally buyer had watched the stock have its worst day in 50 years in August, then saw it make several pushes below the $20 level since then — including after the chief executive got pushed out on Dec. 2 — but fail to get below $18.Photo: FactSet, MarketWatchThen earlier this month, bears took another whack at a sub-$20 move. But after a number of failures to push below $19, let’s say our prerally investor decided to take a chance and buy.With this week’s rally, the stock broke through a well-defined, year-long downward trend line to suggest a new bullish trend has just kicked off. That fact that the trend line had no less than five points on it plus a close call — there only needs to be three points to define a trendline — may give the breakout even more muscle.Photo: FactSet, MarketWatchAfter the stock pulled back on Friday, that prerally buyer may be asking themselves whether they should book at least some profits.There’s a thought among chart watchers that when you’ve reached a crossroads in your decision-making, try to look at the situation through someone else’s eyes.Some would turn the chart upside down and look at it in a mirror.Another way is to pull way back, take a longer-term view of the chart, then ask yourself the opposite question.For example, that prerally buyer should look at a five-year chart, and rather than wonder whether they should sell some, ask themselves: “Would I buy that?”From that perspective, it looks like the stock just ran into a massive overhang of resistance that has already worked once. So the answer to the original question becomes easier: Sell at least some, perhaps enough to lower the breakeven point of the position below the support zone. While there are technical signs the trade could very well work out long term, it could be quite a slog.Photo: FactSet, MarketWatchPreviously broken support levels tend to morph into resistance when they are retested. And the more important the support, the stronger the resistance becomes. The idea is that those who bought at support, and still held it through the breakdown, would likely become sellers happy to break even if given the chance.For Intel’s stock, support around $25 first tested in October 2022 was huge, as it stopped an 18-month drop that appeared to have started accelerating. The third attempt by bears to break that support failed miserably, and launched a doubling in the stock price.That resistance worked very well in bulls’ first attempt at a rally, so there’s a good chance it’ll work again, at least for a while. Even if it does give way, it won’t be easy, and the prerally buyer would probably have to suffer through multiple pullbacks that question their resolve.And if or when the resistance breaks, there’s another zone of resistance just above, at the top of the August 2024 breakdown gap, followed by previously strong prebreakdown support around the $30 level.So a quick booking of some profit would not only ease any coming stress, it would also provide some options depending on what happens next. Trading positions don’t need to be all or nothing, as the amount sold to book some profit could always be repurchased on a dip or after confirmation of a breakout.The chance, and urge, to repurchase could come quite soon. Despite all the daunting resistance, bulls have done enough short-term work to provide some real hope that something bigger is building.Photo: FactSet, MarketWatchThere’s should now be strong support just below current prices, as bears should be unwilling to try another push lower. And while previous bounces off support petered out well below the 200-day moving average, which is viewed by many as a long-term trend dividing line, the latest has peaked above that line — twice.The kicker is, the underlying rate-of-change indicator shows momentum has been building for a rally for months, as each failure by bears to break support actually added to bulls’ strength.While rising momentum at a time when the stock stays flat for falls — bullish technical divergence — isn’t a reason by itself to buy, it can act as a warning for when a breakout does come to take the rally seriously.So other than the prerally buyer, what message may these charts be sending to someone who is considering taking a shot at buying?It’s probably best not to buy within the long-term resistance zone — but perhaps be ready to buy on the dip into close support (with a stop loss on a break of $18). And if resistance does eventually give way, the new trend will likely be a pretty long one.","news_type":1},"isVote":1,"tweetType":1,"viewCount":367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":403679967486256,"gmtCreate":1739578847969,"gmtModify":1739587367300,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a> happy valentine<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a> happy valentine<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a>&nbsp;","text":"$Tiger Brokers(TIGR)$ happy valentine$Roku Inc(ROKU)$","images":[{"img":"https://community-static.tradeup.com/news/9cd5411fac51f6c3444fe39a0e0c6b13","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/403679967486256","isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":403454853476424,"gmtCreate":1739523799646,"gmtModify":1739523805157,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a> after long wait","listText":"<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/ROKU\">$Roku Inc(ROKU)$&nbsp;</a> after long wait","text":"$Roku Inc(ROKU)$ $Roku Inc(ROKU)$ $Roku Inc(ROKU)$ after long wait","images":[{"img":"https://community-static.tradeup.com/news/00acb7877231dff92045030dfa424eba","width":"588","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/403454853476424","isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0}],"hots":[{"id":416933179142616,"gmtCreate":1742791471694,"gmtModify":1742805914615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage","images":[{"img":"https://community-static.tradeup.com/news/ffaf1c513cfadb19fec35402ad5f97e2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":9,"repostSize":97,"link":"https://ttm.financial/post/416933179142616","isVote":1,"tweetType":1,"viewCount":2198,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"idStr":"4178332581629092","authorIdStr":"4178332581629092"},"content":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","text":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","html":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":382603205132640,"gmtCreate":1734443997221,"gmtModify":1734492329425,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a> 5$ soon&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a> 5$ soon&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ 5$ soon @Barcode @TigerGPT @Tiger_SG","images":[{"img":"https://community-static.tradeup.com/news/80fb0a6db8ee66d377f8a3a2a33ea29e","width":"1068","height":"1112"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":104,"commentSize":17,"repostSize":723,"link":"https://ttm.financial/post/382603205132640","isVote":1,"tweetType":1,"viewCount":15169,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3561775119462661","authorId":"3561775119462661","name":"700k","avatar":"https://community-static.tradeup.com/news/c822cf27b8c85ca6e6d8dd110dc73ab1","crmLevel":3,"crmLevelSwitch":1,"idStr":"3561775119462661","authorIdStr":"3561775119462661"},"content":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike","text":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike","html":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":382306116657496,"gmtCreate":1734313280872,"gmtModify":1734314437962,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> go go&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> go go&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ go go @TigerGPT $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/55dff79059585e883aa3822ef60623d7","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":76,"commentSize":5,"repostSize":190,"link":"https://ttm.financial/post/382306116657496","isVote":1,"tweetType":1,"viewCount":4933,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"idStr":"4178332581629092","authorIdStr":"4178332581629092"},"content":"hahaha good that we hold back then , cheers bro","text":"hahaha good that we hold back then , cheers bro","html":"hahaha good that we hold back then , cheers bro"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":365761250451480,"gmtCreate":1730297749639,"gmtModify":1730297754803,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v> it's glitch.. 60$ is loading.. @<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a> you're strong analysis required here to save me 😭😭😭<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v> it's glitch.. 60$ is loading.. @<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a> you're strong analysis required here to save me 😭😭😭<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Trump Media & Technology(DJT)$ it's glitch.. 60$ is loading.. @@Barcode you're strong analysis required here to save me 😭😭😭$Trump Media & Technology(DJT)$","images":[{"img":"https://community-static.tradeup.com/news/8304d61ca4c1f496dff7959b8d678db8","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":30,"commentSize":2,"repostSize":46,"link":"https://ttm.financial/post/365761250451480","isVote":1,"tweetType":1,"viewCount":1524,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":1,"crmLevelSwitch":0,"idStr":"4171900329979952","authorIdStr":"4171900329979952"},"content":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC","text":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC","html":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":360392226762880,"gmtCreate":1729005597010,"gmtModify":1729090802934,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> <a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><a href=\"https://ttm.financial/S/NDX\">$NASDAQ 100(NDX)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/.SPX\">$.SPX(.SPX)$&nbsp;</a>&nbsp; <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Why!!!&nbsp;","listText":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> <a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><a href=\"https://ttm.financial/S/NDX\">$NASDAQ 100(NDX)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/.SPX\">$.SPX(.SPX)$&nbsp;</a>&nbsp; <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Why!!!&nbsp;","text":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"$NVIDIA Corp(NVDA)$ $Aspen Aerogels(ASPN)$ $Tiger Brokers(TIGR)$$NASDAQ 100(NDX)$ $.SPX(.SPX)$ @Barcode @TigerGPT Why!!!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":16,"commentSize":10,"repostSize":40,"link":"https://ttm.financial/post/360392226762880","isVote":1,"tweetType":1,"viewCount":3202,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":1,"crmLevelSwitch":0,"idStr":"4171900329979952","authorIdStr":"4171900329979952"},"content":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!","text":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!","html":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373078257447032,"gmtCreate":1732093999131,"gmtModify":1732094757800,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$ @Barcode @TigerGPT $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":1,"link":"https://ttm.financial/post/373078257447032","isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","text":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","html":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357784684560448,"gmtCreate":1728359249847,"gmtModify":1728359254332,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp;","listText":"<a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp;","text":"$Vincera Pharma, Inc.(VINC)$ buy soon before the blast","images":[{"img":"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/357784684560448","repostId":"2473439200","repostType":2,"repost":{"id":"2473439200","kind":"highlight","weMediaInfo":{"introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"media_name":"MT Newswires Live","id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"pubTimestamp":1728335132,"share":"https://ttm.financial/m/news/2473439200?lang=&edition=full_marsco","pubTime":"2024-10-08 05:05","market":"fut","language":"en","title":"Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2473439200","media":"MT Newswires Live","summary":"Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation studyThe VIP943 antibody-drug conj","content":"<html><body><p> Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation study</p><p>The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.</p><p>Another data update is expected by the end of the year, the company said.</p><p>In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.</p><p>Vincerx expects a cash runway into early 2025.</p><p>Shares of the company jumped 15% in after-hours activity.</p><p>Price: 0.8000, Change: +0.10, Percent Change: +14.61</p></body></html>","source":"mtnewswires_news","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-08 05:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation study</p><p>The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.</p><p>Another data update is expected by the end of the year, the company said.</p><p>In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.</p><p>Vincerx expects a cash runway into early 2025.</p><p>Shares of the company jumped 15% in after-hours activity.</p><p>Price: 0.8000, Change: +0.10, Percent Change: +14.61</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.mtnewswires.com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2473439200","content_text":"Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation studyThe VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.Another data update is expected by the end of the year, the company said.In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.Vincerx expects a cash runway into early 2025.Shares of the company jumped 15% in after-hours activity.Price: 0.8000, Change: +0.10, Percent Change: +14.61","news_type":1},"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"idStr":"4178332581629092","authorIdStr":"4178332581629092"},"content":"No bro, I don't have. Got potential?","text":"No bro, I don't have. Got potential?","html":"No bro, I don't have. Got potential?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":395890978775528,"gmtCreate":1737678282682,"gmtModify":1737682437074,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"Waiting badly to come out <a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a>//<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>:<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","listText":"Waiting badly to come out <a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a>//<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>:<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","text":"Waiting badly to come out $Tiger Brokers(TIGR)$ //@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","images":[{"img":"https://community-static.tradeup.com/news/36e1a03ebfce38f4157e6ed684a6395b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/395890978775528","repostId":"395780312817800","repostType":1,"repost":{"id":395780312817800,"gmtCreate":1737651533089,"gmtModify":1737652153528,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4171900329979952","authorIdStr":"4171900329979952"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","text":"$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","images":[{"img":"https://community-static.tradeup.com/news/36e1a03ebfce38f4157e6ed684a6395b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/395780312817800","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":873,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions.","text":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions.","html":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":359982707662896,"gmtCreate":1728914281313,"gmtModify":1728962890491,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> <a href=\"https://ttm.financial/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a> Join the drone show mate <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>&nbsp;","listText":"<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> <a href=\"https://ttm.financial/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a> Join the drone show mate <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>&nbsp;","text":"@Barcode @TigerGPT $Red Cat Holdings Inc.(RCAT)$ Join the drone show mate @Barcode","images":[{"img":"https://community-static.tradeup.com/news/43de5c6940a9de395327a63d8faa4797"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":119,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/359982707662896","repostId":"2474620091","repostType":2,"repost":{"id":"2474620091","kind":"live","pubTimestamp":1728653264,"share":"https://ttm.financial/m/news/2474620091?lang=&edition=full_marsco","pubTime":"2024-10-11 21:27","market":"us","language":"en","title":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2474620091","media":"THOMSON REUTERS","summary":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","content":"<html><body><p>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</p></body></html>","source":"reuters_en_live","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-11 21:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1><strong>THOMSON REUTERS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2474620091","content_text":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","news_type":1},"isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions.","text":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions.","html":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":355097240260968,"gmtCreate":1727695748144,"gmtModify":1727695752582,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/55fde4cd68f9f90ffa342d47a7d33a2d","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/355097240260968","isVote":1,"tweetType":1,"viewCount":409,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"content":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation","text":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation","html":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":410631949181224,"gmtCreate":1741278021010,"gmtModify":1741278024495,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"The investor summit is currently<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a> happening. It might be a good opportunity to secure some funding.","listText":"The investor summit is currently<a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a> happening. It might be a good opportunity to secure some funding.","text":"The investor summit is currently $Tonix Pharmaceuticals(TNXP)$ happening. It might be a good opportunity to secure some funding.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/410631949181224","repostId":"410630392594784","repostType":1,"repost":{"id":410630392594784,"gmtCreate":1741277520410,"gmtModify":1741277523662,"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4178332581629092","authorIdStr":"4178332581629092"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> Someone has any ideas why the stock suddenly goes up... another manipulation?&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> Someone has any ideas why the stock suddenly goes up... another manipulation?&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ Someone has any ideas why the stock suddenly goes up... another manipulation?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410630392594784","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370645816070368,"gmtCreate":1731507876729,"gmtModify":1731507880947,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$&nbsp;</a><v-v data-views=\"1\"></v-v>im exhausted from all the misleading positive reports, only to see stocks stagnate&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a> answer me why&nbsp;<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$&nbsp;</a> is not performing well.&nbsp;","listText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$&nbsp;</a><v-v data-views=\"1\"></v-v>im exhausted from all the misleading positive reports, only to see stocks stagnate&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a> answer me why&nbsp;<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$&nbsp;</a> is not performing well.&nbsp;","text":"$NIO Inc.(NIO)$ im exhausted from all the misleading positive reports, only to see stocks stagnate @Barcode @TigerGPT answer me why $NIO Inc.(NIO)$ is not performing well.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/370645816070368","repostId":"2482908630","repostType":2,"repost":{"id":"2482908630","kind":"highlight","pubTimestamp":1731481232,"share":"https://ttm.financial/m/news/2482908630?lang=&edition=full_marsco","pubTime":"2024-11-13 15:00","market":"us","language":"en","title":"Is Nio About to Shift Into a Higher Gear?","url":"https://stock-news.laohu8.com/highlight/detail?id=2482908630","media":"Motley Fool","summary":"Nio has shed almost half its value in 2024, but it's gaining momentum to shift into a higher gear in 2025.","content":"<html><head></head><body><ul style=\"\"><li><p>Nio has recorded six straight months of 20,000-plus vehicle deliveries.</p></li><li><p>The Chinese EV maker is now officially delivering Onvo L60 vehicles.</p></li><li><p>Nio will launch another sub-brand later in 2024 -- a likely boost to sales.</p></li></ul><p>Investing in Chinese electric vehicle (EV) makers such as <a href=\"https://laohu8.com/S/NIO\">Nio</a> is an intriguing option. Heavy government subsidies have led to rapid advancement in battery technology and bringing down costs, which makes for an incredibly competitive EV market in China. In fact, China&#39;s market is so far ahead of the U.S. that over half its new vehicle sales were EVs in July.</p><p>The good news for Nio investors is that the company has momentum and could be about to shift into a higher gear. Let&#39;s see what&#39;s ahead.</p><h2 id=\"id_773572304\">Delivery momentum</h2><p>Nio has quietly put together a few months of strong delivery numbers. In fact, for six straight months, Nio has delivered over 20,000 vehicles. Nio delivered 20,976 vehicles in October, which was a 30.5% gain from the prior year.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2aa7d8e419c8c15f516f3d42e79cc8cd\" alt=\"Data source: Nio production and delivery releases. Chart by author.\" title=\"Data source: Nio production and delivery releases. Chart by author.\" tg-width=\"700\" tg-height=\"544\"/><span>Data source: Nio production and delivery releases. Chart by author.</span></p><p>But the biggest takeaway from the October results was early Onvo deliveries. The Nio brand sold 16,657 vehicles in October, while its &#34;family oriented smart vehicle brand,&#34; Onvo, delivered 4,319 in its first full month of sales. After launching the mid-size Onvo L60 in September, management noted that production and deliveries would steadily ramp up.</p><p>At the end of October, Nio had 166 Onvo centers and spaces across 60 cities with plans to expand its network to drive growth. Nio&#39;s Onvo L60 is a good bet for that growth and could shift the company into higher gear. The new electric SUV starts at roughly $21,200 and is aimed directly at competing with rival Tesla&#39;s Model Y.</p><h2 id=\"id_4088032995\">Next step</h2><p>Not only will the Onvo L60 help shift Nio&#39;s deliveries into higher gear, it&#39;s just a stepping stone to what could be an even bigger hit among consumers. Nio CEO William Li commented: &#34;If you think the L60 is good, then this new model is a much more competitive product.&#34; Currently, the plans are for Onvo to launch a new EV every year, with the new mid- to large-size electric SUV due next year.</p><p>Nio isn&#39;t stopping with Onvo. It has plans to launch another, more affordable, sub-brand named &#34;Firefly&#34; late in 2024. In a Chinese market where EVs represented over 50% of new vehicle sales in July -- and which is craving affordable EVs -- Nio&#39;s launch of Onvo and Firefly should really kick the company&#39;s deliveries into a higher gear. We&#39;re seeing evidence of that as recently as October production and delivery figures.</p><p>The good news is that Nio recently announced a cash injection from a group of investors putting up roughly $1.9 billion to help fund its expansion and growth. The collection of strategic investors will invest roughly $471 million in Nio China, while Nio the parent company has agreed to pour in roughly $1.43 billion in cash to subscribe to the newly issued Nio China shares.</p><p>While Nio has shed roughly 44% of its value in 2024 alone, the company is setting itself up for a much stronger 2025.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Nio About to Shift Into a Higher Gear?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Nio About to Shift Into a Higher Gear?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2024/11/12/is-nio-about-to-shift-into-a-higher-gear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nio has recorded six straight months of 20,000-plus vehicle deliveries.The Chinese EV maker is now officially delivering Onvo L60 vehicles.Nio will launch another sub-brand later in 2024 -- a likely ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/11/12/is-nio-about-to-shift-into-a-higher-gear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2024/11/12/is-nio-about-to-shift-into-a-higher-gear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2482908630","content_text":"Nio has recorded six straight months of 20,000-plus vehicle deliveries.The Chinese EV maker is now officially delivering Onvo L60 vehicles.Nio will launch another sub-brand later in 2024 -- a likely boost to sales.Investing in Chinese electric vehicle (EV) makers such as Nio is an intriguing option. Heavy government subsidies have led to rapid advancement in battery technology and bringing down costs, which makes for an incredibly competitive EV market in China. In fact, China's market is so far ahead of the U.S. that over half its new vehicle sales were EVs in July.The good news for Nio investors is that the company has momentum and could be about to shift into a higher gear. Let's see what's ahead.Delivery momentumNio has quietly put together a few months of strong delivery numbers. In fact, for six straight months, Nio has delivered over 20,000 vehicles. Nio delivered 20,976 vehicles in October, which was a 30.5% gain from the prior year.Data source: Nio production and delivery releases. Chart by author.But the biggest takeaway from the October results was early Onvo deliveries. The Nio brand sold 16,657 vehicles in October, while its \"family oriented smart vehicle brand,\" Onvo, delivered 4,319 in its first full month of sales. After launching the mid-size Onvo L60 in September, management noted that production and deliveries would steadily ramp up.At the end of October, Nio had 166 Onvo centers and spaces across 60 cities with plans to expand its network to drive growth. Nio's Onvo L60 is a good bet for that growth and could shift the company into higher gear. The new electric SUV starts at roughly $21,200 and is aimed directly at competing with rival Tesla's Model Y.Next stepNot only will the Onvo L60 help shift Nio's deliveries into higher gear, it's just a stepping stone to what could be an even bigger hit among consumers. Nio CEO William Li commented: \"If you think the L60 is good, then this new model is a much more competitive product.\" Currently, the plans are for Onvo to launch a new EV every year, with the new mid- to large-size electric SUV due next year.Nio isn't stopping with Onvo. It has plans to launch another, more affordable, sub-brand named \"Firefly\" late in 2024. In a Chinese market where EVs represented over 50% of new vehicle sales in July -- and which is craving affordable EVs -- Nio's launch of Onvo and Firefly should really kick the company's deliveries into a higher gear. We're seeing evidence of that as recently as October production and delivery figures.The good news is that Nio recently announced a cash injection from a group of investors putting up roughly $1.9 billion to help fund its expansion and growth. The collection of strategic investors will invest roughly $471 million in Nio China, while Nio the parent company has agreed to pour in roughly $1.43 billion in cash to subscribe to the newly issued Nio China shares.While Nio has shed roughly 44% of its value in 2024 alone, the company is setting itself up for a much stronger 2025.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3205,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576140222331577","authorId":"3576140222331577","name":"Guavaxf30","avatar":"https://static.tigerbbs.com/1ff15ff6aa254c9130f9af922f7e2447","crmLevel":9,"crmLevelSwitch":1,"idStr":"3576140222331577","authorIdStr":"3576140222331577"},"content":"My opinion is Nio has been dragged down by the overall sentiments on China and EV’s (Trump withdrawal of Tax credits). But the negative perception on Chinese actions may turn if we see actual improvements in the economy. As for the removal of EV tax credits, firstly it is speculation that may not happen. Secondly, Chinese EV’s are not allowed into the US anyway. So what the heck?","text":"My opinion is Nio has been dragged down by the overall sentiments on China and EV’s (Trump withdrawal of Tax credits). But the negative perception on Chinese actions may turn if we see actual improvements in the economy. As for the removal of EV tax credits, firstly it is speculation that may not happen. Secondly, Chinese EV’s are not allowed into the US anyway. So what the heck?","html":"My opinion is Nio has been dragged down by the overall sentiments on China and EV’s (Trump withdrawal of Tax credits). But the negative perception on Chinese actions may turn if we see actual improvements in the economy. As for the removal of EV tax credits, firstly it is speculation that may not happen. Secondly, Chinese EV’s are not allowed into the US anyway. So what the heck?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389498675929496,"gmtCreate":1736132963538,"gmtModify":1736132967148,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$ </a> why it's raising&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$ </a> why it's raising&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","text":"$CN Energy Group Inc.(CNEY)$ why it's raising @Boybabyrage @TigerGPT","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://ttm.financial/post/389498675929496","isVote":1,"tweetType":1,"viewCount":1155,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"I apologize, but I couldn't find any specific news or information regarding the recent price movement of CN Energy Group Inc. (CNEY) on January 6th, 2025. The price movement could be influenced by various factors such as market sentiments, company news, earnings reports, or other market dynamics that are not easily identifiable at the moment. To stay updated on the latest news and developments related to CN Energy Group Inc., I recommend monitoring reputable financial news sources or conducting further research. Additionally, consulting with a financial advisor or broker may provide you with more insights tailored to your investment goals and risk tolerance. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and consider your own investment objectives before making any investment decisions.","text":"I apologize, but I couldn't find any specific news or information regarding the recent price movement of CN Energy Group Inc. (CNEY) on January 6th, 2025. The price movement could be influenced by various factors such as market sentiments, company news, earnings reports, or other market dynamics that are not easily identifiable at the moment. To stay updated on the latest news and developments related to CN Energy Group Inc., I recommend monitoring reputable financial news sources or conducting further research. Additionally, consulting with a financial advisor or broker may provide you with more insights tailored to your investment goals and risk tolerance. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and consider your own investment objectives before making any investment decisions.","html":"I apologize, but I couldn't find any specific news or information regarding the recent price movement of CN Energy Group Inc. (CNEY) on January 6th, 2025. The price movement could be influenced by various factors such as market sentiments, company news, earnings reports, or other market dynamics that are not easily identifiable at the moment. To stay updated on the latest news and developments related to CN Energy Group Inc., I recommend monitoring reputable financial news sources or conducting further research. Additionally, consulting with a financial advisor or broker may provide you with more insights tailored to your investment goals and risk tolerance. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and consider your own investment objectives before making any investment decisions."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":405085459796392,"gmtCreate":1739918741057,"gmtModify":1739937578827,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v> there you go&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v> there you go&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;","text":"$Intel(INTC)$ there you go $Intel(INTC)$ @Barcode @TigerGPT","images":[{"img":"https://community-static.tradeup.com/news/41c6496ea10ce42274171e97836f8ae0","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":1,"link":"https://ttm.financial/post/405085459796392","isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions.","text":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions.","html":"Here is the latest information about Intel (INTC): Stock Quote: The current quote data for Intel (INTC) is not available at the moment. You can check the real-time quote on the Tiger Trade platform or other financial websites. Company Profile: Intel is a leading technology company specializing in semiconductor manufacturing. They recently released their latest quarterly figures, which showed solid results with easy beats across the board. However, the outlook for Q1 was a miss across the board, indicating seasonal weakness. The company is facing challenges in gross margins due to Lunar Lake, but they expect Panther Lake and improvements in Intel Foundry to help boost the margin profile. The Q1 revenue guidance is between $11.7 billion and $12.7 billion, with a gross margin forecast of 36% and flat EPS. Intel also mentioned that 7 out of 10 PCs are powered by their technology. You can find more information in this article: Intel Bearish With No CEO, Should You Buy The Dip? Please note that the stock quote data and the article provide general information and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to do thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":395391263375480,"gmtCreate":1737557657429,"gmtModify":1737557661366,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/GOEV\">$Canoo Inc.(GOEV)$&nbsp;</a> game over!!! Does anyone have any hope??","listText":"<a href=\"https://ttm.financial/S/GOEV\">$Canoo Inc.(GOEV)$&nbsp;</a> game over!!! Does anyone have any hope??","text":"$Canoo Inc.(GOEV)$ game over!!! Does anyone have any hope??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/395391263375480","isVote":1,"tweetType":1,"viewCount":797,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3564523401524294","authorId":"3564523401524294","name":"LSM505","avatar":"https://static.tigerbbs.com/468af63413b512390f0fef7427869cf1","crmLevel":5,"crmLevelSwitch":0,"idStr":"3564523401524294","authorIdStr":"3564523401524294"},"content":"Just bought few day ago , cheap is not good ! How my share ?","text":"Just bought few day ago , cheap is not good ! How my share ?","html":"Just bought few day ago , cheap is not good ! How my share ?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":350570611851584,"gmtCreate":1726624327290,"gmtModify":1726625581941,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a> just a good start..thanks to the mid-autumn festival&nbsp;","listText":"<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/LUNR\">$Intuitive Machines(LUNR)$&nbsp;</a> just a good start..thanks to the mid-autumn festival&nbsp;","text":"$Intuitive Machines(LUNR)$ $Intuitive Machines(LUNR)$ just a good start..thanks to the mid-autumn festival","images":[{"img":"https://community-static.tradeup.com/news/d827e18a59295d88274cb9dda19303f6","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":25,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/350570611851584","isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":380534752395336,"gmtCreate":1733955039574,"gmtModify":1733974294402,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TBLA\">$Taboola Com Ltd(TBLA)$</a> <a href=\"https://ttm.financial/S/TBLA\">$Taboola Com Ltd(TBLA)$</a> still not selling <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TBLA\">$Taboola Com Ltd(TBLA)$</a> <a href=\"https://ttm.financial/S/TBLA\">$Taboola Com Ltd(TBLA)$</a> still not selling <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a>&nbsp;","text":"$Taboola Com Ltd(TBLA)$ $Taboola Com Ltd(TBLA)$ still not selling @Barcode @TigerGPT","images":[{"img":"https://community-static.tradeup.com/news/2ee79339e0fd3e4e5690e804a861d5f0","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/380534752395336","isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"Based on the latest information available for Taboola Com Ltd (TBLA): Stock Name: Taboola Com Ltd Stock Code: TBLA Stock Price: $4.26 (USD) Yesterday's Closing Price: $4.08 (USD) 52-Week High: $5.00 (USD) 52-Week Low: $2.87 (USD) Market Capitalization: $1.43 billion (USD) Circulating Market Cap: $769.68 million (USD) Total Share Capital: 336.21 million Float Share Capital: 180.68 million Price-to-Earnings Ratio (TTM): -44.277 Price-to-Sales Ratio (TTM): 0.85 Price-to-Book Ratio: 1.42 Earnings per Share (LYR): -$0.24 Earnings per Share (TTM): -$0.10 Return on Assets (ROA): -0.46% Return on Equity (ROE): -3.19% Trading Volume: 2.43 million shares Trading Value: $10.29 million (USD) Volume Ratio: 1.39 Analyst Recommendations: 1 recommend 5 buy 1 hold Analyst Target Price: Mean: $5.33 (USD) Low: $5.00 (USD) High: $6.00 (USD) Recent News: Taboola Signs New Content Recommendations Deal With Future, Extending Partnership Into 12th Year Read more Taboola.com Signs New 3-Year Deal With WeatherBug Read more Taboola and WeatherBug Announce New, Exclusive Multi-Year Deal Read more Please note that the stock information provided is for reference purposes only and does not constitute investment advice. It is recommended to conduct thorough research and analysis before making any investment decisions.","text":"Based on the latest information available for Taboola Com Ltd (TBLA): Stock Name: Taboola Com Ltd Stock Code: TBLA Stock Price: $4.26 (USD) Yesterday's Closing Price: $4.08 (USD) 52-Week High: $5.00 (USD) 52-Week Low: $2.87 (USD) Market Capitalization: $1.43 billion (USD) Circulating Market Cap: $769.68 million (USD) Total Share Capital: 336.21 million Float Share Capital: 180.68 million Price-to-Earnings Ratio (TTM): -44.277 Price-to-Sales Ratio (TTM): 0.85 Price-to-Book Ratio: 1.42 Earnings per Share (LYR): -$0.24 Earnings per Share (TTM): -$0.10 Return on Assets (ROA): -0.46% Return on Equity (ROE): -3.19% Trading Volume: 2.43 million shares Trading Value: $10.29 million (USD) Volume Ratio: 1.39 Analyst Recommendations: 1 recommend 5 buy 1 hold Analyst Target Price: Mean: $5.33 (USD) Low: $5.00 (USD) High: $6.00 (USD) Recent News: Taboola Signs New Content Recommendations Deal With Future, Extending Partnership Into 12th Year Read more Taboola.com Signs New 3-Year Deal With WeatherBug Read more Taboola and WeatherBug Announce New, Exclusive Multi-Year Deal Read more Please note that the stock information provided is for reference purposes only and does not constitute investment advice. It is recommended to conduct thorough research and analysis before making any investment decisions.","html":"Based on the latest information available for Taboola Com Ltd (TBLA): Stock Name: Taboola Com Ltd Stock Code: TBLA Stock Price: $4.26 (USD) Yesterday's Closing Price: $4.08 (USD) 52-Week High: $5.00 (USD) 52-Week Low: $2.87 (USD) Market Capitalization: $1.43 billion (USD) Circulating Market Cap: $769.68 million (USD) Total Share Capital: 336.21 million Float Share Capital: 180.68 million Price-to-Earnings Ratio (TTM): -44.277 Price-to-Sales Ratio (TTM): 0.85 Price-to-Book Ratio: 1.42 Earnings per Share (LYR): -$0.24 Earnings per Share (TTM): -$0.10 Return on Assets (ROA): -0.46% Return on Equity (ROE): -3.19% Trading Volume: 2.43 million shares Trading Value: $10.29 million (USD) Volume Ratio: 1.39 Analyst Recommendations: 1 recommend 5 buy 1 hold Analyst Target Price: Mean: $5.33 (USD) Low: $5.00 (USD) High: $6.00 (USD) Recent News: Taboola Signs New Content Recommendations Deal With Future, Extending Partnership Into 12th Year Read more Taboola.com Signs New 3-Year Deal With WeatherBug Read more Taboola and WeatherBug Announce New, Exclusive Multi-Year Deal Read more Please note that the stock information provided is for reference purposes only and does not constitute investment advice. It is recommended to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":365126332117112,"gmtCreate":1730185776865,"gmtModify":1730185781579,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a>&nbsp;","text":"$Intel(INTC)$ $Intel(INTC)$","images":[{"img":"https://community-static.tradeup.com/news/9e444fca050df6da786b6d724525dd70","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/365126332117112","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"10000000000010968","authorId":"10000000000010968","name":"Tiger_CashBoostAccount","avatar":"https://community-static.tradeup.com/news/ae2d4002ef9664aba005cb3020f416f5","crmLevel":1,"crmLevelSwitch":0,"idStr":"10000000000010968","authorIdStr":"10000000000010968"},"content":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🤩🎉 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","text":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🤩🎉 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","html":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🤩🎉 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":362415423643656,"gmtCreate":1729500202788,"gmtModify":1729576218942,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Any good news about&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Any good news about&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$ @TigerGPT Any good news about $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/e362eabb7e02e343c08758e0ce97a5ea","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/362415423643656","isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"idStr":"4141429963588842","authorIdStr":"4141429963588842"},"content":"I found some news related to Tonix Pharmaceuticals (TNXP): Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides a real-time stock price quote for Tonix Pharmaceuticals, along with breaking news, financials, statistics, charts, and more. TNXP Tonix Pharmaceuticals Holding Corp. - Seeking Alpha: This article offers a high-level overview of Tonix Pharmaceuticals, covering the latest stock price, chart, news, analysis, fundamentals, and trading tools. Tonix Pharmaceuticals (TNXP) Stock Price, News & Analysis - MarketBeat: This report discusses Tonix Pharmaceuticals' quarterly earnings results. The company reported earnings per share of ($19.28) for the quarter, missing the consensus estimate of ($9.91) by $9.37. Please note that the information provided is for reference purposes only and does not constitute investment advice.","text":"I found some news related to Tonix Pharmaceuticals (TNXP): Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides a real-time stock price quote for Tonix Pharmaceuticals, along with breaking news, financials, statistics, charts, and more. TNXP Tonix Pharmaceuticals Holding Corp. - Seeking Alpha: This article offers a high-level overview of Tonix Pharmaceuticals, covering the latest stock price, chart, news, analysis, fundamentals, and trading tools. Tonix Pharmaceuticals (TNXP) Stock Price, News & Analysis - MarketBeat: This report discusses Tonix Pharmaceuticals' quarterly earnings results. The company reported earnings per share of ($19.28) for the quarter, missing the consensus estimate of ($9.91) by $9.37. Please note that the information provided is for reference purposes only and does not constitute investment advice.","html":"I found some news related to Tonix Pharmaceuticals (TNXP): Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides a real-time stock price quote for Tonix Pharmaceuticals, along with breaking news, financials, statistics, charts, and more. TNXP Tonix Pharmaceuticals Holding Corp. - Seeking Alpha: This article offers a high-level overview of Tonix Pharmaceuticals, covering the latest stock price, chart, news, analysis, fundamentals, and trading tools. Tonix Pharmaceuticals (TNXP) Stock Price, News & Analysis - MarketBeat: This report discusses Tonix Pharmaceuticals' quarterly earnings results. The company reported earnings per share of ($19.28) for the quarter, missing the consensus estimate of ($9.91) by $9.37. Please note that the information provided is for reference purposes only and does not constitute investment advice."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":356319976865976,"gmtCreate":1728001656230,"gmtModify":1728001660188,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SAVE\">$Spirit Airlines(SAVE)$</a> <a href=\"https://ttm.financial/S/SAVE\">$Spirit Airlines(SAVE)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/SAVE\">$Spirit Airlines(SAVE)$</a> <a href=\"https://ttm.financial/S/SAVE\">$Spirit Airlines(SAVE)$</a>&nbsp;","text":"$Spirit Airlines(SAVE)$ $Spirit Airlines(SAVE)$","images":[{"img":"https://community-static.tradeup.com/news/ebcf1baec2b131412ab39023378c4008","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/356319976865976","isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}